The Biotechnology and Biological Sciences Research Council (BBSRC) and the Medical Research Council (MRC) will run the public dialogue programme to gain an insight into public attitudes towards stem cell research. In this fast moving and important area of science it is essential to know public concerns, views and attitudes, as well as to provide an opportunity for scientists to discuss with the public the challenges that researchers face and the potential benefits from this challenging field of research.
The programme of activities will be sponsored by the Sciencewise unit of the Department of Trade and Industry. It will aim to bring scientists and the public together to identify public expectations, aspirations and concerns about stem cell research.
Speaking at a meeting of leading experts in the field of stem cells in London today, Mr Wicks said: "The Government believes that stem cell research offers enormous potential to deliver new treatments for many devastating diseases where there is currently no effective cure. Huge numbers of people are affected by these diseases and Britain is a world-leader in stem cell research. But there must be a proper dialogue with the wider public on the future of stem cell research. We need to raise public awareness about the potential opportunities and challenges in this area, and that is why this new Sciencewise programme is so important. "
A key element will be to raise awareness about world-class stem cell research in the UK and the progress that is being made towards potential treatments, while communicating realistic examples of its potential.
Professor Julia Goodfellow, BBSRC Chief Executive, said: "It is essential that scientists working in areas such as stem cell research engage in a real dialogue with the public. The new programme will give scientists, funders and the government up-to-date information on what the public really think about stem cell research while giving people the chance to voice their views and concerns. It will also allow the science community to talk to people about the first-class stem cell science in the UK and what the realistic applications are likely to be."
Professor Colin Blakemore, MRC Chief Executive "Scientists who work on stem cells want to ensure they maintain the trust and support of the public for their research. But to achieve this, we need to explain what work is being carried out and why it's being done. We also want to make sure that people are aware of the possibilities of research, what it's realistically likely to achieve, and, above all, the importance of meticulous and careful research that takes ethical issues into account. And we must do everything possible to be sure that potential treatments are safe before they are tested on patients.
"Open dialogue will raise awareness among scientists as well as members of the public. And it could also help us to move more quickly towards potential therapies. Discussion will help to make scientists understand the potential of their work and policy-makers aware of the public's views. In turn, this might lead to laboratory discoveries being applied more quickly in the clinic."
BBSRC and MRC have been awarded a Sciencewise grant of £300,000 to run the programme.
Press Office | alfa
Mass spectrometry sheds new light on thallium poisoning cold case
14.12.2018 | University of Maryland
Protein involved in nematode stress response identified
14.12.2018 | University of Illinois College of Agricultural, Consumer and Environmental Sciences
The more objects we make "smart," from watches to entire buildings, the greater the need for these devices to store and retrieve massive amounts of data quickly without consuming too much power.
Millions of new memory cells could be part of a computer chip and provide that speed and energy savings, thanks to the discovery of a previously unobserved...
What if, instead of turning up the thermostat, you could warm up with high-tech, flexible patches sewn into your clothes - while significantly reducing your...
A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth – this was discovered by researchers from the University of Basel’s Biozentrum two years ago. In a follow-up study, recently published in “Cell Reports”, the scientists report that this drug cocktail induces cancer cell death by switching off their energy supply.
The widely used anti-diabetes drug metformin not only reduces blood sugar but also has an anti-cancer effect. However, the metformin dose commonly used in the...
A research team from the University of Zurich has developed a new drone that can retract its propeller arms in flight and make itself small to fit through narrow gaps and holes. This is particularly useful when searching for victims of natural disasters.
Inspecting a damaged building after an earthquake or during a fire is exactly the kind of job that human rescuers would like drones to do for them. A flying...
Over the last decade, there has been much excitement about the discovery, recognised by the Nobel Prize in Physics only two years ago, that there are two types...
12.12.2018 | Event News
10.12.2018 | Event News
06.12.2018 | Event News
14.12.2018 | Power and Electrical Engineering
14.12.2018 | Physics and Astronomy
14.12.2018 | Physics and Astronomy